Research lines of Colorectal cancer

Reading time: 1 min

Current lines of colorectal cancer research are divided into 3 groups:

  • Immunometabolomic studies, aimed at identifying biomarkers that predict treatment response, resistance and prognosis, to personalise therapy.
  • Translational studies on chromosomal instability using liquid biopsies (analysis of tumour genetic material in blood) and tumour tissue analyses.
  • Various clinical trials to find new alternatives for patients. 

Liquid biopsy (circulating tumour DNA). A liquid biopsy analyses genetic tumour material found in the patient’s blood (circulating tumour DNA).

Various studies into liquid biopsies are currently underway. Some studies aim to detect which patients can benefit from adjuvant chemotherapy (postoperative intention-to-cure chemotherapy). There are also studies designed to monitor changes in the tumour biology observed in metastatic patients to discover whether a patient is resistant to a new therapy and so it needs to be changed.

What is Cancer?

General information about Cancer

Read more

Substantiated information by:

Antonio Maria Lacy Fortuny
Estela Pineda Losada
Francesc Balaguer Prunes
Mª Rosa Costa Quintàs

Published: 20 February 2018
Updated: 9 October 2025

The donations that can be done through this webpage are exclusively for the benefit of Hospital Clínic of Barcelona through Fundació Clínic per a la Recerca Biomèdica and not for BBVA Foundation, entity that collaborates with the project of PortalClínic.

Subscribe

Receive the latest updates related to this content.

Thank you for subscribing!

If this is the first time you subscribe you will receive a confirmation email, check your inbox

An error occurred and we were unable to send your data, please try again later.